Molecular insights into macrolide resistant Mycoplasma pneumoniae isolates from outpatient clinics in Tehran, Iran. [PDF]
Arfaatabar M +3 more
europepmc +1 more source
Effect of Macrolide Resistance and Mycoplasma pneumoniae DNA Load in Bronchoalveolar Lavage Fluid on Immune and Inflammatory Responses in Children with Mycoplasma pneumoniae Pneumonia. [PDF]
Zhong H, Zeng Z, Gu H, Dong X.
europepmc +1 more source
Correction: LncNFYC-AS1 ameliorates Mycoplasma pneumoniae pneumonia via regulating miR- 1323. [PDF]
Chen C, Hu J, Guo M, Li L, Yang Q.
europepmc +1 more source
Risk factors and clinical characteristics of fulminant Mycoplasma pneumoniae pneumonia in children: a retrospective case‒control study. [PDF]
Ren Y, Lin Y, Dai J.
europepmc +1 more source
Comparison of severe and general Mycoplasma pneumoniae pneumonia in children: a targeted next-generation sequencing based study. [PDF]
Lu S, Zhou N, Song X, Song X, Qiao X.
europepmc +1 more source
Immunogenicity Evaluation of Six Key Antigens of <i>Mycoplasma pneumoniae</i> in BALB/c Mice. [PDF]
Huang L, Zhang H, Xiao H, Li Z, Li Q.
europepmc +1 more source
Macrolide Resistance and P1 Cytadhesin Genotyping of Mycoplasma pneumoniae during Outbreak, Canada, 2024-2025. [PDF]
Fatima Z +6 more
europepmc +1 more source
Epidemiological characteristics of Mycoplasma pneumoniae in hospitalized children before during and after the COVID-19 pandemic in xi'an China. [PDF]
Liu N +6 more
europepmc +1 more source
The Role of NLR and Ferritin Levels as Biomarkers for Corticosteroid Dosage in Children with Refractory <i>Mycoplasma Pneumoniae</i> Pneumonia. [PDF]
Guo C, Cheng Y, Song C, Wang X, Li Y.
europepmc +1 more source

